Fabio Zuccotto Selected Research

Fabio Zuccotto Research Topics

8	Visceral Leishmaniasis (Kala Azar) 12/2023 - 01/2018
4	Tuberculosis (Tuberculoses) 10/2022 - 12/2016
3	Chagas Disease (American Trypanosomiasis) 10/2023 - 01/2020
3	Neoplasms (Cancer) 09/2015 - 07/2013
2	Malaria 01/2019 - 01/2015
1	Cardiotoxicity 11/2023
1	Gram-Negative Bacterial Infections 04/2023
1	Trypanosomiasis 01/2022
1	Neglected Diseases 11/2021
1	Plague (Bubonic Plague) 11/2019
1	Cryptosporidiosis 01/2019
1	Infections 01/2019
1	Neoplasm Metastasis (Metastasis) 07/2013
1	Melanoma (Melanoma, Malignant) 07/2013

3	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2023 - 01/2019
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 07/2023 - 01/2018
2	Proteasome InhibitorsIBA 10/2023 - 01/2021
2	Lysine-tRNA LigaseIBA 10/2022 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2018 - 12/2016
2	Phosphotransferases (Kinase)IBA 01/2018 - 07/2013
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 11/2013
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 12/2023
1	benzofuranIBA 11/2023
1	benzothiopheneIBA 01/2021
1	EnzymesIBA 11/2019
1	miltefosine (Impavido)IBA 01/2019
1	LactamsIBA 10/2018
1	GSK3186899IBA 01/2018
1	GuanineIBA 01/2017
1	IsoindolesIBA 09/2015
1	DDD107498IBA 01/2015
1	Guanosine Triphosphate (GTP)IBA 01/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	Peptide Elongation Factor 2 (EF-2)IBA 01/2015
1	compound 18IBA 11/2013
1	NMS-E973IBA 07/2013

4	Therapeutics 04/2023 - 09/2015
1	Oral Administration 01/2019